| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 140,407 | 92,852 | ||
| Accounts receivable, net | 120,370 | 86,172 | ||
| Prepaid expenses and other current assets | 13,066 | 12,729 | ||
| Total current assets | 273,843 | 191,753 | ||
| Property and equipment, net | 3,666 | 3,929 | ||
| Operating lease right-of-use assets | 9,775 | 10,201 | ||
| Intangible assets, net | 2,247 | 2,453 | ||
| Deferred tax assets | 101,687 | 129,459 | ||
| Other assets | 4,844 | 5,151 | ||
| Total assets | 396,062 | 342,946 | ||
| Accounts payable | 1,613 | 1,389 | ||
| Accrued research and development costs | 3,528 | 4,551 | ||
| Accrued expenses and other current liabilities | 34,620 | 24,033 | ||
| Current portion of operating lease liabilities | 3,236 | 3,220 | ||
| Current portion of convertible senior notes | 199,506 | 199,332 | ||
| Total current liabilities | 242,503 | 232,525 | ||
| Operating lease obligations, net of current portion | 10,498 | 11,117 | ||
| Revolving credit facility | 385,000 | 385,000 | ||
| Other liabilities | 22,218 | 22,466 | ||
| Class a common stock, 0.001 par value, 500,000,000 shares authorized and 162,678,647 shares issued and outstanding at september 30, 2025 and 500,000,000 shares authorized and 160,205,899 shares issued and outstanding at december 31, 2024 | 163 | 162 | ||
| Additional paid-in capital | 1,408,836 | 1,405,224 | ||
| Accumulated deficit | -1,671,442 | -1,711,522 | ||
| Accumulated other comprehensive income (loss) | -1,714 | -2,026 | ||
| Total stockholders' deficit | -264,157 | -308,162 | ||
| Total liabilities and stockholders' deficit | 396,062 | 342,946 | ||
IRONWOOD PHARMACEUTICALS INC (IRWD)
IRONWOOD PHARMACEUTICALS INC (IRWD)